» Articles » PMID: 25397678

NK Cell Activity Differs Between Patients with Localized and Diffuse Cutaneous Leishmaniasis Infected with Leishmania Mexicana: a Comparative Study of TLRs and Cytokines

Overview
Journal PLoS One
Date 2014 Nov 15
PMID 25397678
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Leishmania mexicana causes localized (LCL) or diffuse cutaneous leishmaniasis (DCL). The cause of dissemination in DCL remains unknown, yet NK cells possibly play a role in activating leishmanicidal mechanisms during innate and adaptive immune responses. We had previously shown that Leishmania lipophosphoglycan (LPG) is a ligand for TLR2, activating human NK cells. We have now analyzed NK cells in LCL and DCL patients. NK numbers and effector mechanisms differed drastically between both groups of patients: DCL patients showed reduced NK cell numbers; diminished IFN-γ and TNF-α production; and lower TLR2, TLR1, and TLR6 expression as compared to LCL patients. The altered protein expression found in NK cells of DCL patients correlated with their down-regulation of IFN-γ gene expression in LPG-stimulated and non-stimulated cells as compared to LCL patients. NK cell response was further analyzed according to gender, age, and disease evolution in LCL patients showing that female patients produced higher IFN-γ levels throughout the disease progression, whereas TLR2 expression diminished in both genders with prolonged disease evolution and age. We furthermore show the activation pathway of LPG binding to TLR2 and demonstrated that TLR2 forms immunocomplexes with TLR1 and TLR6. In addition to the reduced NK cell numbers in peripheral blood, DCL patients also showed reduced NK cell numbers in the lesions. They were randomly scattered within the lesions, showing diminished cytokine production, which contrasts with those of LCL lesions, where NK cells produced IFN-γ and TNF-α and were found within organized granulomas. We conclude that in DCL patients the reduced NK-cell numbers and their diminished activity, evidenced by low TLR expression and low cytokine production, are possibly involved in the severity of the disease. Our results provide new information on the contribution of NK cells in Leishmania infections of the human host.

Citing Articles

Unveiling the Interplay Between Dendritic Cells and Natural Killer Cells as Key Players in Infection.

Valerio-Bolas A, Meunier M, Rodrigues A, Palma-Marques J, Ferreira R, Cardoso I J Immunol Res. 2025; 2025:3176927.

PMID: 39963187 PMC: 11832263. DOI: 10.1155/jimr/3176927.


Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis.

Lafleur A, Daffis S, Mowbray C, Arana B Vaccines (Basel). 2024; 12(10).

PMID: 39460345 PMC: 11511131. DOI: 10.3390/vaccines12101179.


Th17 Cell and Inflammatory Infiltrate Interactions in Cutaneous Leishmaniasis: Unraveling Immunopathogenic Mechanisms.

Morales-Primo A, Becker I, Pedraza-Zamora C, Zamora-Chimal J Immune Netw. 2024; 24(2):e14.

PMID: 38725676 PMC: 11076297. DOI: 10.4110/in.2024.24.e14.


and : An Untold Story of Coinfection.

Camelo G, Silva J, Geiger S, Melo M, Negrao-Correa D Trop Med Infect Dis. 2023; 8(8).

PMID: 37624321 PMC: 10458104. DOI: 10.3390/tropicalmed8080383.


Leishmania mexicana Lipophosphoglycan Activates Dermal γδ T Cells with Participation of TLR2.

Soto-Olguin N, Zamora-Chimal J, Delgado-Dominguez J, Becker I Acta Parasitol. 2022; 68(1):122-129.

PMID: 36434381 DOI: 10.1007/s11686-022-00639-w.


References
1.
Faria M, Reis F, Lima A . Toll-like receptors in leishmania infections: guardians or promoters?. J Parasitol Res. 2012; 2012:930257. PMC: 3317170. DOI: 10.1155/2012/930257. View

2.
Tuon F, Fernandes E, Duarte M, Amato V . The expression of TLR2, TLR4 and TLR9 in the epidermis of patients with cutaneous leishmaniasis. J Dermatol Sci. 2010; 59(1):55-7. DOI: 10.1016/j.jdermsci.2010.04.009. View

3.
Srivastava A, Singh N, Mishra M, Kumar V, Gour J, Bajpai S . Identification of TLR inducing Th1-responsive Leishmania donovani amastigote-specific antigens. Mol Cell Biochem. 2011; 359(1-2):359-68. DOI: 10.1007/s11010-011-1029-5. View

4.
Ajdary S, Alimohammadian M, Eslami M, Kemp K, Kharazmi A . Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun. 2000; 68(4):1760-4. PMC: 97345. DOI: 10.1128/IAI.68.4.1760-1764.2000. View

5.
Nylen S, Eidsmo L . Tissue damage and immunity in cutaneous leishmaniasis. Parasite Immunol. 2012; 34(12):551-61. DOI: 10.1111/pim.12007. View